Skip to main content

Advertisement

SpringerLink
Log in

Evaluation of fracture risk in chronic kidney disease

  • Review
  • Published:
Journal of Nephrology Aims and scope Submit manuscript

Abstract

Chronic kidney disease (CKD) is associated with mineral and bone disorders (MBD) that are now considered as a syndrome. Bone fragility and a four to tenfold increased rate of skeletal fractures are often reported in CKD patients. The evaluation of the risk of these fractures in CKD patients should explore the same risk factors identified for the general population including low body weight, menopause, personal and familial history of osteoporosis, chronic inflammatory diseases, and corticosteroid therapy. The aim of this article is to provide a critical review of the tools used for the evaluation of bone loss and the risk of fracture in CKD patients, ranging from the measurement of bone mineral density (BMD), fracture risk assessment (Frax™), quantitative computed tomography (QCT), high-resolution peripheral quantitative computed tomography (HRpQTC), to circulating biomarkers of bone metabolism including vitamin D, parathyroid hormone (PTH), bone-specific alkaline phosphatase, osteocalcin, and some collagen type 1-related molecules indicators of bone remodeling.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Dhayat NA, Ackermann D, Pruijm M et al (2016) Fibroblast growth factor 23 and markers of mineral metabolism in individuals with preserved renal function. Kidney Int 90(3):648–657

    Article  CAS  PubMed  Google Scholar 

  2. Urena-Torres P, Prie D, Keddad K et al (2014) Changes in fibroblast growth factor 23 levels in normophosphatemic patients with chronic kidney disease stage 3 treated with lanthanum carbonate: results of the PREFECT study, a phase 2a, double blind, randomized, placebo-controlled trial. BMC Nephrol 15:71

    Article  PubMed  PubMed Central  Google Scholar 

  3. Naylor KL, McArthur E, Leslie WD et al (2014) The three-year incidence of fracture in chronic kidney disease. Kidney Int 86(4):810–818

    Article  PubMed  Google Scholar 

  4. Ensrud KE, Parimi N, Cauley JA et al (2013) Cystatin C and risk of hip fractures in older women. J Bone Miner Res 28(6):1275–1282

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Ensrud KE, Parimi N, Fink HA et al (2014) Estimated GFR and risk of hip fracture in older men: comparison of associations using cystatin C and creatinine. Am J Kidney Dis 63(1):31–39

    Article  CAS  PubMed  Google Scholar 

  6. Jadoul M, Albert JM, Akiba T et al (2006) Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. Kidney Int 70(7):1358–1366

    Article  CAS  PubMed  Google Scholar 

  7. Tentori F, McCullough K, Kilpatrick RD et al (2014) High rates of death and hospitalization follow bone fracture among hemodialysis patients. Kidney Int 85(1):166–173

    Article  PubMed  Google Scholar 

  8. Maravic M, Ostertag A, Urena P, Cohen-Solal M (2016) Dementia is a major risk factor for hip fractures in patients with chronic kidney disease. Osteoporos Int 27(4):1665–1669

    Article  CAS  PubMed  Google Scholar 

  9. Klawansky S, Komaroff E, Cavanaugh PF Jr et al (2003) Relationship between age, renal function and bone mineral density in the US population. Osteoporos Int 14(7):570–576

    Article  CAS  PubMed  Google Scholar 

  10. KDIGO (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl 113:S1–S130

  11. Jassal SK, von Muhlen D, Barrett-Connor E (2007) Measures of renal function, BMD, bone loss, and osteoporotic fracture in older adults: the Rancho Bernardo study. J Bone Miner Res 22(2):203–210

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Kuipers AL, Egwuogu H, Evans RW et al (2015) Renal function and bone loss in a Cohort of Afro-Caribbean Men. J Bone Miner Res 30(12):2215–2220

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Ersoy FF, Passadakis SP, Tam P et al (2006) Bone mineral density and its correlation with clinical and laboratory factors in chronic peritoneal dialysis patients. J Bone Miner Metab 24(1):79–86

    Article  PubMed  Google Scholar 

  14. Gerakis A, Hadjidakis D, Kokkinakis E, Apostolou T, Raptis S, Billis A (2000) Correlation of bone mineral density with the histological findings of renal osteodystrophy in patients on hemodialysis. J Nephrol 13(6):437–443

    CAS  PubMed  Google Scholar 

  15. Jamal SA, Chase C, Goh YI, Richardson R, Hawker GA (2002) Bone density and heel ultrasound testing do not identify patients with dialysis-dependent renal failure who have had fractures. Am J Kidney Dis 39(4):843–849

    Article  PubMed  Google Scholar 

  16. Negri AL, Barone R, Quiroga MA et al (2004) Bone mineral density: serum markers of bone turnover and their relationships in peritoneal dialysis. Perit Dial Int 24(2):163–168

    PubMed  Google Scholar 

  17. Piraino B, Chen T, Cooperstein L, Segre G, Puschett J (1988) Fractures and vertebral bone mineral density in patients with renal osteodystrophy. Clin Nephrol 30(2):57–62

    CAS  PubMed  Google Scholar 

  18. Atsumi K, Kushida K, Yamazaki K, Shimizu S, Ohmura A, Inoue T (1999) Risk factors for vertebral fractures in renal osteodystrophy. Am J Kidney Dis 33(2):287–293

    Article  CAS  PubMed  Google Scholar 

  19. Elder GJ, Mackun K (2006) 25-Hydroxyvitamin D deficiency and diabetes predict reduced BMD in patients with chronic kidney disease. J Bone Miner Res 21(11):1778–1784

    Article  CAS  PubMed  Google Scholar 

  20. Fontaine MA, Albert A, Dubois B, Saint-Remy A, Rorive G (2000) Fracture and bone mineral density in hemodialysis patients. Clin Nephrol 54(3):218–226

    CAS  PubMed  Google Scholar 

  21. Jamal SA, Gilbert J, Gordon C, Bauer DC (2006) Cortical pQCT measures are associated with fractures in dialysis patients. J Bone Miner Res 21(4):543–548

    Article  PubMed  Google Scholar 

  22. Kaji H, Suzuki M, Yano S et al (2002) Risk factors for hip fracture in hemodialysis patients. Am J Nephrol 22(4):325–331

    Article  PubMed  Google Scholar 

  23. Urena P, Bernard-Poenaru O, Ostertag A et al (2003) Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients. Nephrol Dial Transplant 18(11):2325–2331

    Article  CAS  PubMed  Google Scholar 

  24. Yamaguchi T, Kanno E, Tsubota J, Shiomi T, Nakai M, Hattori S (1996) Retrospective study on the usefulness of radius and lumbar bone density in the separation of hemodialysis patients with fractures from those without fractures. Bone 19(5):549–555

    Article  CAS  PubMed  Google Scholar 

  25. Bucur RC, Panjwani DD, Turner L, Rader T, West SL, Jamal SA (2015) Low bone mineral density and fractures in stages 3–5 CKD: an updated systematic review and meta-analysis. Osteoporos Int 26(2):449–458

    Article  CAS  PubMed  Google Scholar 

  26. Iimori S, Mori Y, Akita W et al (2012) Diagnostic usefulness of bone mineral density and biochemical markers of bone turnover in predicting fracture in CKD stage 5D patients–a single-center cohort study. Nephrol Dial Transplant 27(1):345–351

    Article  CAS  PubMed  Google Scholar 

  27. Naylor KL, Garg AX, Zou G et al (2015) Comparison of fracture risk prediction among individuals with reduced and normal kidney function. Clin J Am Soc Nephrol 10(4):646–653

    Article  PubMed  PubMed Central  Google Scholar 

  28. West SL, Lok CE, Langsetmo L et al (2015) Bone mineral density predicts fractures in chronic kidney disease. J Bone Miner Res 30(5):913–919

    Article  PubMed  Google Scholar 

  29. Yenchek RH, Ix JH, Shlipak MG et al (2012) Bone mineral density and fracture risk in older individuals with CKD. Clin J Am Soc Nephrol 7(7):1130–1136

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Jamal SA, West SL, Nickolas TL (2014) The clinical utility of FRAX to discriminate fracture status in men and women with chronic kidney disease. Osteoporos Int 25(1):71–76

    Article  CAS  PubMed  Google Scholar 

  31. Malluche HH, Mawad HW, Monier-Faugere MC (2011) Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients. J Bone Miner Res 26(6):1368–1376

    Article  PubMed  Google Scholar 

  32. Nickolas TL, Stein EM, Dworakowski E et al (2013) Rapid cortical bone loss in patients with chronic kidney disease. J Bone Miner Res 28(8):1811–1820

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Mares J, Ohlidalova K, Opatrna S, Ferda J (2009) Determinants of prevalent vertebral fractures and progressive bone loss in long-term hemodialysis patients. J Bone Miner Metab 27(2):217–223

    Article  PubMed  Google Scholar 

  34. Jamal SA, Swan VJ, Brown JP et al (2010) Kidney function and rate of bone loss at the hip and spine: the Canadian Multicentre Osteoporosis Study. Am J Kidney Dis 55(2):291–299

    Article  PubMed  Google Scholar 

  35. Malluche HH, Davenport DL, Cantor T, Monier-Faugere MC (2014) Bone mineral density and serum biochemical predictors of bone loss in patients with CKD on dialysis. Clin J Am Soc Nephrol 9(7):1254–1262

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Cejka D, Patsch JM, Weber M et al (2011) Bone microarchitecture in hemodialysis patients assessed by HR-pQCT. Clin J Am Soc Nephrol 6(9):2264–2271

    Article  PubMed  PubMed Central  Google Scholar 

  37. Nickolas TL, Jamal SA (2015) Bone kidney interactions. Rev Endocr Metab Disord 16(2):157–163

  38. Hasegawa K, Hasegawa Y, Nagano A (2004) Estimation of bone mineral density and architectural parameters of the distal radius in hemodialysis patients using peripheral quantitative computed tomography. J Biomech 37(5):751–756

    Article  PubMed  Google Scholar 

  39. Bacchetta J, Boutroy S, Vilayphiou N et al (2010) Assessment of bone microarchitecture in chronic kidney disease: a comparison of 2D bone texture analysis and high-resolution peripheral quantitative computed tomography at the radius and tibia. Calcif Tissue Int 87(5):385–391

    Article  CAS  PubMed  Google Scholar 

  40. Heaf J (2001) Causes and consequences of adynamic bone disease. Nephron 88(2):97–106

    Article  CAS  PubMed  Google Scholar 

  41. Behets GJ, Spasovski G, Sterling LR et al (2015) Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism. Kidney Int 87(4):846–856

    Article  CAS  PubMed  Google Scholar 

  42. Danese MD, Kim J, Doan QV, Dylan M, Griffiths R, Chertow GM (2006) PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis. Am J Kidney Dis 47(1):149–156

    Article  PubMed  Google Scholar 

  43. Lertdumrongluk P, Lau WL, Park J, Rhee CM, Kovesdy CP, Kalantar-Zadeh K (2013) Impact of age on survival predictability of bone turnover markers in hemodialysis patients. Nephrol Dial Transplant 28(10):2535–2545

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Coco M, Rush H (2000) Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. Am J Kidney Dis 36(6):1115–1121

    Article  CAS  PubMed  Google Scholar 

  45. Fuller DS, Pisoni RL, Bieber BA, Gillespie BW, Robinson BM (2013) The DOPPS Practice Monitor for US dialysis care: trends through December 2011. Am J Kidney Dis 61(2):342–346

    Article  PubMed  Google Scholar 

  46. Fishbane S, Hazzan AD, Jhaveri KD, Ma L, Lacson E Jr (2016) Bone Parameters and Risk of Hip and Femur Fractures in Patients on Hemodialysis. Clin J Am Soc Nephrol 11(6):1063–1072

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Russo CR, Taccetti G, Caneva P, Mannarino A, Maranghi P, Ricca M (1998) Volumetric bone density and geometry assessed by peripheral quantitative computed tomography in uremic patients on maintenance hemodialysis. Osteoporos Int 8(5):443–448

    Article  CAS  PubMed  Google Scholar 

  48. Lu KC, Ma WY, Yu JC, Wu CC, Chu P (2012) Bone turnover markers predict changes in bone mineral density after parathyroidectomy in patients with renal hyperparathyroidism. Clin Endocrinol (Oxf) 76(5):634–642

    Article  CAS  Google Scholar 

  49. Rudser KD, de Boer IH, Dooley A, Young B, Kestenbaum B (2007) Fracture risk after parathyroidectomy among chronic hemodialysis patients. J Am Soc Nephrol 18(8):2401–2407

    Article  PubMed  Google Scholar 

  50. Yajima A, Tanaka K, Tominaga Y et al (2001) Early changes of bone histology and circulating markers of bone turnover after parathyroidectomy in hemodialysis patients with severe hyperparathyroidism. Clin Nephrol 56(1):27–34

    CAS  PubMed  Google Scholar 

  51. Moe SM, Abdalla S, Chertow GM et al (2015) Effects of Cinacalcet on fracture events in patients receiving hemodialysis: the EVOLVE trial. J Am Soc Nephrol 26(6):1466–1475

    Article  CAS  PubMed  Google Scholar 

  52. Urena-Torres P, Metzger M, Haymann JP et al (2011) Association of kidney function, vitamin D deficiency, and circulating markers of mineral and bone disorders in CKD. Am J Kidney Dis 58(4):544–553

    Article  CAS  PubMed  Google Scholar 

  53. Singer RF (2013) Vitamin D in dialysis: defining deficiency and rationale for supplementation. Semin Dial 26(1):40–46

    Article  PubMed  Google Scholar 

  54. Coen G, Mantella D, Manni M et al (2005) 25-hydroxyvitamin D levels and bone histomorphometry in hemodialysis renal osteodystrophy. Kidney Int 68(4):1840–1848

    Article  CAS  PubMed  Google Scholar 

  55. Napoli N, Strollo R, Sprini D, Maddaloni E, Rini GB, Carmina E (2014) Serum 25-OH vitamin D in relation to bone mineral density and bone turnover. Int J Endocrinol 2014:487463

    PubMed  PubMed Central  Google Scholar 

  56. Aggarwal HK, Jain D, Yadav S, Kaverappa V (2013) Bone mineral density in patients with predialysis chronic kidney disease. Ren Fail 35(8):1105–1111

    Article  CAS  PubMed  Google Scholar 

  57. Ambrus C, Almasi C, Berta K et al (2011) Vitamin D insufficiency and bone fractures in patients on maintenance hemodialysis. Int Urol Nephrol 43(2):475–482

    Article  CAS  PubMed  Google Scholar 

  58. Mucsi I, Almasi C, Deak G et al (2005) Serum 25(OH)-vitamin D levels and bone metabolism in patients on maintenance hemodialysis. Clin Nephrol 64(4):288–294

    Article  CAS  PubMed  Google Scholar 

  59. Tomida K, Hamano T, Mikami S et al (2009) Serum 25-hydroxyvitamin D as an independent determinant of 1–84 PTH and bone mineral density in non-diabetic predialysis CKD patients. Bone 44(4):678–683

    Article  CAS  PubMed  Google Scholar 

  60. Bischoff-Ferrari HA, Dawson-Hughes B, Whiting SJ (2011) Vitamin D supplementation and fracture risk. Arch Intern Med 171(3):265 (author reply—6)

    Article  PubMed  Google Scholar 

  61. Reid IR, Gallagher DJ, Bosworth J (1986) Prophylaxis against vitamin D deficiency in the elderly by regular sunlight exposure. Age Ageing 15(1):35–40

    Article  CAS  PubMed  Google Scholar 

  62. Nigwekar SU, Bhan I, Thadhani R (2012) Ergocalciferol and cholecalciferol in CKD. Am J Kidney Dis 60(1):139–156

    Article  CAS  PubMed  Google Scholar 

  63. Ueda M, Inaba M, Okuno S et al (2005) Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH. Life Sci 77(10):1130–1139

    Article  CAS  PubMed  Google Scholar 

  64. Ueda M, Inaba M, Okuno S et al (2002) Clinical usefulness of the serum N-terminal propeptide of type I collagen as a marker of bone formation in hemodialysis patients. Am J Kidney Dis 40(4):802–809

    Article  CAS  PubMed  Google Scholar 

  65. Nickolas TL, Cremers S, Zhang A et al (2011) Discriminants of prevalent fractures in chronic kidney disease. J Am Soc Nephrol 22(8):1560–1572

    Article  PubMed  PubMed Central  Google Scholar 

  66. Hamano T, Tomida K, Mikami S et al (2009) Usefulness of bone resorption markers in hemodialysis patients. Bone 45(Suppl 1):S19–S25

    Article  CAS  PubMed  Google Scholar 

  67. Maeno Y, Inaba M, Okuno S, Yamakawa T, Ishimura E, Nishizawa Y (2005) Serum concentrations of cross-linked N-telopeptides of type I collagen: new marker for bone resorption in hemodialysis patients. Clin Chem 51(12):2312–2317

    Article  CAS  PubMed  Google Scholar 

  68. Okuno S, Inaba M, Kitatani K, Ishimura E, Yamakawa T, Nishizawa Y (2005) Serum levels of C-terminal telopeptide of type I collagen: a useful new marker of cortical bone loss in hemodialysis patients. Osteoporos Int 16(5):501–509

    Article  CAS  PubMed  Google Scholar 

  69. Prie D, Beck L, Urena P, Friedlander G (2005) Recent findings in phosphate homeostasis. Curr Opin Nephrol Hypertens 14(4):318–324

    Article  CAS  PubMed  Google Scholar 

  70. Urena Torres P, Friedlander G, de Vernejoul MC, Silve C, Prie D (2008) Bone mass does not correlate with the serum fibroblast growth factor 23 in hemodialysis patients. Kidney Int 73(1):102–107

    Article  CAS  PubMed  Google Scholar 

  71. Wesseling-Perry K, Pereira RC, Tseng CH et al (2012) Early skeletal and biochemical alterations in pediatric chronic kidney disease. Clin J Am Soc Nephrol 7(1):146–152

    Article  CAS  PubMed  Google Scholar 

  72. Murali SK, Roschger P, Zeitz U, Klaushofer K, Andrukhova O, Erben RG (2016) FGF23 Regulates Bone Mineralization in a 1,25(OH)2 D3 and Klotho-Independent Manner. J Bone Miner Res 31(1):129–142

    Article  CAS  PubMed  Google Scholar 

  73. Carrillo-Lopez N, Panizo S, Alonso-Montes C et al (2016) Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease. Kidney Int 90(1):77–89

    Article  CAS  PubMed  Google Scholar 

  74. Moe S, Drueke T, Cunningham J, Goodman W, Martin K, Olgaard K, Ott S, Sprague S, Lameire N, Eknoyan G (2006) Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 69(11):1945–1953

Download references

Author information

Authors and Affiliations

  1. Ramsay-Générale de Santé, Clinique du Landy, Saint-Ouen, France

    Pablo Antonio Ureña Torres

  2. Department of Renal Physiology, Necker Hospital, University of Paris Descartes, Paris, France

    Pablo Antonio Ureña Torres

  3. INSERM U1132 and USPC Paris-Diderot, Paris, France

    Martine Cohen-Solal

  4. Department of Rheumatology, Hôpital Lariboisière, Paris, France

    Martine Cohen-Solal

Authors
  1. Pablo Antonio Ureña Torres
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Martine Cohen-Solal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pablo Antonio Ureña Torres.

Ethics declarations

Conflict of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Ethical approval

This article does not contain any studies with human participants performed by any of the authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Torres, P.A.U., Cohen-Solal, M. Evaluation of fracture risk in chronic kidney disease. J Nephrol 30, 653–661 (2017). https://doi.org/10.1007/s40620-017-0398-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40620-017-0398-6

Keywords

Search

Navigation